Cargando…
Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience
BACKGROUND: Mucormycosis is an emerging fungal infection in both developed and developing countries with different target population. Unusual isolates and unusual clinical presentations have been reported from India in recent times. OBJECTIVES: The present study was done to know the epidemiology, ri...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225759/ https://www.ncbi.nlm.nih.gov/pubmed/32435094 http://dx.doi.org/10.5005/jp-journals-10071-23387 |
_version_ | 1783534134389374976 |
---|---|
author | Priya, Poorna Ganesan, Vithiya Rajendran, T Geni, VG |
author_facet | Priya, Poorna Ganesan, Vithiya Rajendran, T Geni, VG |
author_sort | Priya, Poorna |
collection | PubMed |
description | BACKGROUND: Mucormycosis is an emerging fungal infection in both developed and developing countries with different target population. Unusual isolates and unusual clinical presentations have been reported from India in recent times. OBJECTIVES: The present study was done to know the epidemiology, risk factors, diagnostic modalities, and treatment outcome of mucormycosis patients in our hospital. MATERIALS AND METHODS: The study was carried out over a period of 4 years from October 2015 to October 2019. This is a retrospective observational chart review of patients diagnosed with proven and probable mucormycosis. Information on demography, clinical features, risk factors, laboratory and radiological findings, treatment (including medical and surgical treatment), and outcome was extracted from the records. Primary outcome at 42 days was determined. RESULTS: Thirty-eight patients were diagnosed with mucormycosis based on microbiological and/or histopathological examination (HPE) of the clinical samples. Most commonly affected age-group was between 41 years and 60 years. More number of cases were reported during the months of post rainy season (September to December). A large number of patients (77%) presented with uncontrolled diabetes mellitus. Rhino-orbito-cerebral mucormycosis was the most common presentation followed by cutaneous infection. Antifungal treatment was started in around 80% of the cases. Twenty patients were managed by combined medical and surgical intervention. Eight patients died while the outcome of nine was unknown, as they left the hospital against medical advice and could not be followed up. CONCLUSION: Mucormycosis, an insidious killer, should be an important differential diagnosis in progressive soft tissue infections and deep organ infection. HOW TO CITE THIS ARTICLE: Priya P, Ganesan V, Rajendran T, Geni VG. Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience. Indian J Crit Care Med 2020;24(3):168–171. |
format | Online Article Text |
id | pubmed-7225759 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Jaypee Brothers Medical Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-72257592020-05-20 Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience Priya, Poorna Ganesan, Vithiya Rajendran, T Geni, VG Indian J Crit Care Med Original Article BACKGROUND: Mucormycosis is an emerging fungal infection in both developed and developing countries with different target population. Unusual isolates and unusual clinical presentations have been reported from India in recent times. OBJECTIVES: The present study was done to know the epidemiology, risk factors, diagnostic modalities, and treatment outcome of mucormycosis patients in our hospital. MATERIALS AND METHODS: The study was carried out over a period of 4 years from October 2015 to October 2019. This is a retrospective observational chart review of patients diagnosed with proven and probable mucormycosis. Information on demography, clinical features, risk factors, laboratory and radiological findings, treatment (including medical and surgical treatment), and outcome was extracted from the records. Primary outcome at 42 days was determined. RESULTS: Thirty-eight patients were diagnosed with mucormycosis based on microbiological and/or histopathological examination (HPE) of the clinical samples. Most commonly affected age-group was between 41 years and 60 years. More number of cases were reported during the months of post rainy season (September to December). A large number of patients (77%) presented with uncontrolled diabetes mellitus. Rhino-orbito-cerebral mucormycosis was the most common presentation followed by cutaneous infection. Antifungal treatment was started in around 80% of the cases. Twenty patients were managed by combined medical and surgical intervention. Eight patients died while the outcome of nine was unknown, as they left the hospital against medical advice and could not be followed up. CONCLUSION: Mucormycosis, an insidious killer, should be an important differential diagnosis in progressive soft tissue infections and deep organ infection. HOW TO CITE THIS ARTICLE: Priya P, Ganesan V, Rajendran T, Geni VG. Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience. Indian J Crit Care Med 2020;24(3):168–171. Jaypee Brothers Medical Publishers 2020-03 /pmc/articles/PMC7225759/ /pubmed/32435094 http://dx.doi.org/10.5005/jp-journals-10071-23387 Text en Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd. © The Author(s). 2020 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Article Priya, Poorna Ganesan, Vithiya Rajendran, T Geni, VG Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience |
title | Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience |
title_full | Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience |
title_fullStr | Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience |
title_full_unstemmed | Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience |
title_short | Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience |
title_sort | mucormycosis in a tertiary care center in south india: a 4-year experience |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225759/ https://www.ncbi.nlm.nih.gov/pubmed/32435094 http://dx.doi.org/10.5005/jp-journals-10071-23387 |
work_keys_str_mv | AT priyapoorna mucormycosisinatertiarycarecenterinsouthindiaa4yearexperience AT ganesanvithiya mucormycosisinatertiarycarecenterinsouthindiaa4yearexperience AT rajendrant mucormycosisinatertiarycarecenterinsouthindiaa4yearexperience AT genivg mucormycosisinatertiarycarecenterinsouthindiaa4yearexperience |